author-photo

Hazem A. Sayala

Leeds Teaching Hospitals NHS Trust

14

Papers

247

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Skeletal-Related Events In Myeloma: A Population-Based Study

2013 Blood
Show All
- Source
- Cite
- Save
Citations (4)
Long Term Survival Report of the UKCLL02 Trial: A Phase II Study of Subcutaneous Alemtuzumab In Patients with Fludarabine Refractory CLL (on Behalf of the NCRI CLL Trials Sub-Group)

2010 Blood
Show All
- Source
- Cite
- Save
Citations (5)
An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL).

2009 Blood
Show All
- Source
- Cite
- Save
Citations (17)
Development of EBV-associated diffuse large B-cell lymphoma in Waldenström macroglobulinemia and mantle cell lymphoma

2008 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (10)
Eradication of Minimal Residual Disease with Alemtuzumab in Chronic Lymphocytic Leukemia Is Associated with Prolonged Survival and Is an Appropriate Theraputic Endpoint for Relapsed CLL.

2007 Blood
Show All
- Source
- Cite
- Save
Citations (7)
NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL.

2007 Blood
Show All
- Source
- Cite
- Save
Citations (10)
Final Report of the UKCLL02 Trial: A Phase II Study of Subcutaneous Alemtuzumab Plus Fludarabine in Patients with Fludarabine Refractory CLL (on Behalf of the NCRI CLL Trials Sub-Group).

2006 Blood
Show All
- Source
- Cite
- Save
Citations (20)
Bi-Allelic Deletion of 13q14 Is Associated with Inferior Progression Free Survival Compared to Mono-Allelic 13q14 Deletion in B-Cell Chronic Lymphocytic Leukaemia.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (0)